Health Cor Management, L.P. Sarepta Therapeutics, Inc. Transaction History

Health Cor Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $4.14 Million - $6.62 Million	-50,280 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $3.85 Million - $6.82 Million	50,280 New	50,280 $6.49 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $70.8 Million - $108 Million	-1,309,960 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $5.11 Million - $6.08 Million	107,190 Added 8.91%	1,309,960 $72.9 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $43 Million - $56.7 Million	1,202,770	1,202,770 $54.6 Million

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.